Jump to Content
Jump to Main Navigation
User Account
Sign In
to save searches and organize your favorite content.
Not registered?
Sign up
My Content
(1)
Recently viewed
(1)
Volume 9 (2011): Issue...
Searches
(0)
More
Subscriptions
Join E-mail List
Help
JNCCN
Menu
Home
Content
Current Issue
Past Issues
Supplements
NCCN Meeting Highlights
JNCCN In the News
CE
JNCCN 360
Author Center
Call for Papers
Submit a Manuscript
Information for Authors
Reprints/Permissions
About
JNCCN
Editorial Board
Editorial Calendar
NCCN
Harborside
Search
Close
Advanced Search
Help
Volume 9 (2011): Issue Suppl_3 (Feb 2011): NCCN Oncology Pharmacy & Policy
in
Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
eTOC Alerts
Ahead of Print Alerts
Citation Alert
Citation Alerts
New NCCN Program Recognizes Organizations Supporting Coverage for Clinical Trials and Appropriate Off-Label Drug Usage
Pages: vii–ix
NCCN Trends
Pages: x
Take Your Medicine
By:
Harold J. Burstein
Pages: S-1
A Quick REMS Update and a Clinical Focus
By:
Edward C. Li
Pages: S-2–S-3
Informing Patients: Translating the NCCN Guidelines
By:
Joan S. McClure
Pages: S-4–S-5
Biosimilars: Approval and Acceptance?
By:
Jessica K. DeMartino
Pages: S-6–S-9
Where Your Data Is Going and Where It's Been
By:
Jane M. Quigley
Pages: S-10–S-12
New Options for the Management of Castration-Resistant Prostate Cancer: A Case Perspective
By:
Dawn Goetz
Pages: S-13–S-24
Pharmacotherapy for Chronic Myelogenous Leukemia: A Case-Based Approach
By:
Stephen Harnicar
Pages: S-25–S-35
Safe and Successful Implementation of CPOE for Chemotherapy at a Children's Cancer Center
By:
James M. Hoffman
,
Donald K. Baker
,
Scott C. Howard
,
Joseph H. Laver
and
Jerry L. Shenep
Pages: S-36–S-50
Save
Email
Share
Share
Share
Collapse
Expand
Search
Issue
Journal
[35.171.146.16]
35.171.146.16
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
